documents: FDA-2017-D-6580-3476

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-6580-3476 FDA FDA-2017-D-6580 Drug Products Labeled as Homeopathic; Draft Guidance for Staff and Industry; Availability; Extension of Comment Period Notice Extension of Comment Period 2018-03-21T04:00:00Z 2018 3 2018-03-21T04:00:00Z 2018-05-22T03:59:59Z 2019-02-02T02:03:50Z 2018-05659 0 0 0900006483035dd8

Links from other tables